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In the past three years a large number of compounds having a property re-
ferred to as histamine neutralizing, histamine antagonistic or antihistaminic have
been described in the literature. Two of these drugs, diphenhydramine hydro-
chloride1 and tripelennamine hydrochloride,2 have been subjected to extensive
experimental and clinical evaluation. These compounds have proven to be
useful adjuncts in the management of some allergic diseases, as well as in some
diseases in which the allergic component is less certain.
A few of the previously reported studies in man have been on a quantitative
basis, for example the early study of Baer and Sulzberger (1). Using a patient
with urticarial dermographism as a subject, these authors were able to measure
the reduction in whealing produced by preceding oral administration of tripelen-
namine hydrochloride, as well as the lack of effectiveness on the flare and some of
the quantitative factors and time-limits involved.
We have studied the effect of Hydryllin8 on man in the clinic (2) and laboratory.
Several different laboratory methods were used in comparing the effectiveness of
Hydryllin with other antihistamine drugs. A procedure in which human sub-
jects rather than laboratory animals were used, was found preferable.
PRELIMINARY STUDIES
1. The first method used involved the measurement of experimental wheals
produced by the intradermal injection of histamine. One-tenth cc. of 1/10,000,
1/100,000 and 1/1,000,000 aqueous solutions of histamine was injected intra-
dermally into the flexor surface of the forearm of each of eight normal persons.
The diameters of the resultant wheal and erythema were measured 10 and 15
minutes later. Equivalent doses of antihistamine compounds were then admin-
istered orally. Four subjects were given Hydryllin, and four others diphen-
hydramine hydrochloride. One hour later the same quantity of the same his..
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1 Name designated by the Council of Pharmacy and Chemistry of the American Medical
Association for beta-dimethyl -aminoethyl-benzhydryl-ether-hydrochloride or Benadryl
hydrochloride.
2 Name adopted by the Council of Pharmacy and chemistry of the American Medical
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chloride or Pyribenzamine hydrochloride.
Hydryllin is a product of the G. D. Searle and Company, Chicago, Ill. A single tablet
contains 100 mgm. of Aminophyllin and 25 mgm. of diphenhydramine.
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tamine solutions was similarly injected into the opposite forearm. The diame-
ters of the second series of wheals and flares (measured at identical time incre-
ments) were compared with those obtained initially. All 8 subjects showed some
decrease in the diameter of the wheal or erythema (or both).
There are several disadvantages to this procedure. The accurate measure-
ment of the diameter of the wheal and erythema is difficult. This difficulty is
increased when pseudopods appear, because of the irregularity of the border.
Similarly, accurate measurement of the erythema is not possible because its
border is not definitely demarcated from normal skin. There are also uncon-
trollable variations in the quantity of histamine injected, the pressure exerted,
and the depth of injection; all of which may influence the size of the wheal and
erythema produced. This method is a rough qualitative means of demon-
strating histamine-neutralizing activity.
2. A second method was studied in four subjects who had positive scratch tests
to ragweed. The diameter of the wheal and erythema produced by scratch tests
with dried ragweed pollen were measured before and one hour after the ingestion
of 50 mgm. of diphenhydramine hydrochloride. There was a definite decrease
in the size of both the wheal and erythema in all 4 subjects. The same objections
to the measurement of the wheal and erythema prevail as previously indicated
for the first method. An additional variable is the disparity in the quantity of
ragweed antigen used in different patients as well as in succeeding tests on the
same patient. This is also only a rough qualitative method of determining
antihistamine activity.
3. During these studies a decrease in the intensity of the erythema was noted
following the administration of an anti-histamine compound. A thermocouple
was used to measure the skin temperature at the site of histamine injection before
and after the administration of a histamine antagonistic drug. The results in
five subjects were, however, inconsistent and not conclusive.
4. Histamine iontophoresis was the fourth method studied and proved to be a
reasonably accurate method of evaluating antihistamine activity in man.
HISTAMINE IONTOPHORE5I5 (ELECTROPHORESIS)
Cohen and Friedman (3) studied the effect of histamine azoprotein (Hapamine)
using iontophoresis. They determined the dilution of histamine phosphate
which produced an initial whealing reaction in each of 50 allergic patients and
compared it with subsequent thresholds obtained in a similar fashion after a
course of Hapamine (at least 5 cc. in 30 days). They found an "average decrease
in reactivity of the threshold of 5.25 multiples". No control studies were re-
reported by these investigators.
Using the same method, Cohen et al. (4), studied the histamine antagonistic
effect of diphenhydramine hydrochloride in twenty patients and found anywhere
"from 2 to 32 order of protection".
In the present experiments a 45 Volt B battery connected in series to a rheostat
and ammeter was used for producing common ion transfer. The positive elec-
trode was a 2 sq. cm. piece of copper and the negative electrode was a piece of
lead sheeting wrapped in gauze.
EFFECT OF ANTI-HISTAMINE DRUGS 463
Histamine dilutions were freshly prepared for each experiment, using 1 cc.
ampoules of histamine acid phosphate (Lilly), which contain the equivalent of
1 mgm. of active histamine. The diluent was a specially prepared buffered
neutral solution
Serial solutions ranging from 1/500,000 to 1/10,000,000 of histamine base
were prepared. Dry tuberculin syringes were used to mix each solution. Pieces
of filter paper (2 cm. square) were saturated with the dilution to be tested,
placed on the flexor surface of the forearm and covered by the positive (copper)
electrode. A constant weight,1 equally suspended on each side of the forearm,
was placed on this electrode (Fig. 1). The current was then induced and main-
tained at 2 milliamperes for 2 minutes. Following the introduction of histamine,
the site was carefully observed for 10 minutes for a whealing reaction. The
copper electrode was then washed with tap water and dried before the next test.
FIG. 1. Apparatus used for iontophoresis of multiple dilutions of histamine. The long
object in the foreground is a weighted sling for maintenance of pressure on the positive
electrode.
In this manner, the threshold level, which was the highest dilution producing
punctate follicular whealing, was determined for each patient. Comparisons
were made with the diluent solution, which served as the control. After the
patient's threshold was determined, the anti-histamne drug to be tested was
administered. At 30, 60 and 120 minute intervals the threshold values were
again determined. After the first 20 experiments, 30-minute readings were dis-
continued because there seemed to be very little measurable anti-histamine
activity in this time; some patients had only slight threshold changes until 120
A. Stock Solution
NaH2PO4 28.81 gm.
Na2HPO4 125.00 gm.
Distilled water 1000.00 gm.
B. Stock Solution 20.00 cc.
NaCl 8.50 gm.
Distilled water (q.a.) 1000.00 cc.
The weight consisted of a sling of linen cloth, each end of which enclosed a sand filled
bottle weighing 1.22 Kg.
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minutes. In five patients, 150-minute threshold levels were the same as at 120
minutes. Consequently, in the experiments reported herein, the observations
were terminated 2 hours after the anti-histamine compound was administered.
RESULTS OBTAINED
1. Cohen and Friedman (3) reported that 45 of their patients had an initial
histamine threshold of 1/6,400,000 and 5 had a level of 1/3,200,000. The dilu-
tions used by these investigators were made in geometric progression. Thus far,
we have determined the initial threshold in 80 normal subjects, using serial
dilutions of histamine base. The reaction range varied from 1/900,000 to 1/9,-
000,000. Table I illustrates the comparative results in the two groups.
TABLE I
Range of initial histamine threshold in 80 subjects compared with 50 subjects in Cohen and
Friedman's study
IISSTAMINE (BASE) DILUTION NUMBER OF PATIENTS
1/900,000 2
1/1,000,000 7
1/2,000,000 9
1/3,000,000 10
1/3,000,000
1/4,000,000 15
1/5,000,000 13
1/6,000,000 11
1/6,000,000 45
1/7,000,000 10
1/8,000,000 2
1/9,000,000 1
These findings demonstrate considerably more variation in the initial thresh-
old response than those reported by Cohen and Friedman, probably due to the
fact that the dilutions employed in the present experiments were in smaller
increments. Fifty-nine of the 80 subjects had an initial threshold ranging from
1/3,000,000 to 1/7,000,000. Thus, the majority of the subjects reactedwithina
comparable range.
2. In order to compare the antihistamine effect of different drugs, 60 subjects
were studied in the following manner:
A. 10 subjects received placebo capsules
B. 10 subjects received aminophyllin (250 mgm.)
C. 10 subjects received ephedrine sulphate 25 mgm.)
D. 10 subjects received diphenhydramine hydrochloride (50 mgm.)
E. 10 subjects received triplennamine hydrochloride (50 mgm.)
F. 10 subjects received Hydryllin (2 tablets, containing a total of 50 mgm. of
diphenhydramine and 200 mgm. of aminophyllin).
In each of the 60 subjects the experiments were performed in the previously
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described manner using the six substances enumerated above. Each dilution
of histamine contained a certain concentration of histamine base as indicated
in Table II.
TABLE II
Tabulation of the histamine base content in each of a group of serial solutions
HISTAMINE BASE I)ILUTION QUANTITY OP HISTAMINE BASE
1/500,000
1/600,000
1/700,000
1/800,000
1/900,000
1/1,000,000
1/2,000,000
1/3,000,000
1/4,000,000
1/5,000,000
1/6,000,000
1/7,000,000
1/8,000,000
1/9,000,000
1/10,000,000
(micrograms per cc. of soiulioH)
2.000
1.666
1.428
1.250
1.111
1.000
0.500
0.333
0.250
0.200
0.166
0.142
0.125
0.111
0.100
TABLE III
Averagequantity of histamine base neutralized by each of the drugs tested
DRUG PLACEBO
DIPITENHY-
'J'
CHLORIDE
TRIPELEN-
CHLORIDE
HYDRYLLIN
Average two hour histamine
salt concentration*, (10 sub-
jects)
Average initial histamine salt
concentration* (10 subjects)
Average difference in Hista-
mine salt concentration.
(Average amount of hista-
mine neutralized)
0.303
0.303
0.000
0.497
0.473
0.024
0.521
0.343
0.178
0.948
0.214
0.734
1.026
0.290
0.736
1.118
0.36&
0.752
* Micrograms of histamine base per cc. of solution.
All threshold levels were converted into their corresponding weight values of
histamine, obtained from Table II. The initial and the two-hour threshold
histamine concentrations were averaged for the ten subjects tested with each of
the six drugs studied. The difference between the average two hour and initial
histamine concentrations represents the average quantity of histamine neu-
tralized (Table III).
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For example, the average difference in histamine concentration in the diphen-
hydramine hydrochloride series is 0.734 micrograms of histamine base per cc. of
solution. This is obtained by subtracting 0.124 (the average initial histamine
salt coicentration in 10 subjects, before diphenhydramine hydrochloride was
administered) from 0.948 (the average two-hour histamine salt concentration
obtained in the same 10 subjects, after diphenhydramine hydrochloride was
ingested). Similarly, the average quantity of histamine neutralized was com-
puted for the placebo, aminophyllin, ephedrine sulfate, tripelennamine hydro-
chloride and ilydryllin groups of subjects.
The determination of the average "fold of protection" afforded by each of the
substances tested is another method of comparing the results obtained in the 60
0
PLP1CEBO MNO- EPHEDRINE DPHEM- ThIPEt.ENN— MYDP.'i'L.LIN
PHYLUM SULF1E HYDAM%NE AM%NE
HC1. HCt
Fm. 2. Average "fold of protection" against histamine administered by iontophoresis.
The slight differences between diphenhydramine HC1, Tripelennamine HCI and Hydryllin
are of no statistical significance.
experiments. The method of computing the "fold of protection" may be demon-
strated by the results of one experiment. The initial threshold of the subject
was 1/500,000 or 0.2 micrograms of histamine base per cc. of solution. Two
hours after the ingestion of 50 mgm. of diphenhydramine hydrochloride, the
threshold was 1/1,000,000 or 1.0 micrograms of histamine base per cc. To ob-
tain the "fold of protection" the latter figure is divided by the initial threshold;
thus, 1.0 micrograms divided by 0.2 micrograms equals 5. This patient, there-
fore, obtained a five fold protection. In other words, 50 mgm. of diphenhydra-
mine hydrochloride protected the skin against five times as much histamine.
Figure 2 illustrates the average "fold of protection" obtained with each of the
drugs tested. There were ten patients in each group. The absence of histamine
neutralization by placeboes is shown. Aminophyllin afforded no protection in 7
subjects, but in 3 gave a little protection. The average for all 10 was 0.38.
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Diphenhydramine hydrochloride had an average fold of protection of 4.31,
tripelennamine hydrochloride 4.44, Hydryllin 4.95 and ephedrine sulfate 1.51.
DISCUSSION
Several findings seem worthy of discussing. First of all, placebo capsules
(containing sugar) have no histamine neutralizing capacity, indicating that the
lontophoresis method is reasonably devoid of errors due to psychic influences.
In no placebo experiment was the patient aware of the inert nature of the cap-
sules given him. Secondly, there is some indication that several individuals
(3 of 10 tested) apparently derived a slight anti-histamine effect from the doses
of aminophyllin used (250 mgm.). Loew et al. (5) reported that aminophyllin,
in a dosage of 50 mgm./kg. of body weight, effected a 30% reduction of mortality
in guinea pigs subjected to atomized histamine. However, this was a larger
dose than was given our human subjects. Thirdly, ephedrine, which is known
to be useful in the management of some allergic diseases (6), apparently has some
histamine neutralizing capacity. However, this ability is approximately only
one-third of the anti-histamine capacity of diphenhydramine hydrochloride,
tripelennamine hydrochloride and Hydryllin. Finally, diphenhydramine hy-
drochloride, tripelennamine hydrochloride and Hydryllin apparently have the
greatest histamine neutralizing capacity of all the drugs tested. Although there
seemed to be slight differences in their histamine antagonistic activity, these did
not prove to be statistically significant when subjected to analysis by the method
of standard error of differences. Consequently, the results of our experiments
indicate that comparable dosages of these three drugs have approximately the
same capacity to neutralize histamine.
The whealing reaction obtained at different levels of the flexor surface of the
forearm seemed to have varying degrees of intensity of reaction. In each of
10 patients the threshold dilution was determined. Using the same solution
ascending and descending tests were performed on the flexor surface of each
forearm. Only one subject had the same intensity of reaction from the elbow
to the palmar border. The remainder had the same intensity of reaction along
the forearms to a site approximately 7.5 to 10 cm. from the palm. Seven of
these subjects showed a definite decrease in the intensity of response within
this area, whereas 2 subjects had entirely no response in the same area. The
obvious inference is to avoid this area when using histamine iontophoresis for
purposes such as ours.
Cohen and Friedman (3) recommended iontophoresis "because there is little
non-specific irritation of the skin and also there is no significant variation in the
amount of the test substance which enters the skin. This is because the method
uses a non-irritating current of standard amount, standard time and size. The
only variable is the strength of the test solution." They used a 1 sq. cm. copper
electrode and a current of 1 milliampere for 3 minutes. In the present experi-
ments a 2 sq. cm. copper electrode and a current of 2 milliamperes for 2 minutes
was used throughout. In addition, constant pressure on the positive electrode
was maintained.
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Tontophoresis with histamine has some limitations. While the threshold levels
are ordinarily easy to determine, occasional difficulty arises from the appearance
of a few (2—6) follicular wheals instead of the diffuse punctate folicular whealing
which is regarded as the threshold level. In such instances comparison must be
made with the control solution applied to an adjacent area of the forearms. If a
similar small number of wheals follow electrophoresis of the control, the correct
threshold level has not been reached, and more dilutions must be tested.
It is believed, however, that histamine iontophoresis is the best of the four
experimental methods which were used to determine the histamine neutralizing
capacity of anti-histamine drugs. It is more nearly a quantitative approach
than any of the other methods used. It permits utilization of human subjects
rather than laboratory animals. It offers a feasible means of comparing the
histamine neutralizing capacity of different drugs.
CONCLUSIONS
1. Histamine iontophoresis (electrophoresis) is superior to three other methods
described for testing the histamine-neutralizing capacity of certain drugs.
2. lontophoresis is a method which allows comparison of the histamine neu-
tralizing ability of different drugs in human subjects.
3. In 80 subjects studied, the initial threshold response to histamine adminis-
tered by electrophoresis varied from dilutions of 1/900,000 to 1/9,000,000. The
majority ranged, however, between 1/3,000,000 and 1/7,000,000.
4. Placeboes had no histamine neutralizing capacity. Five drugs tested on a
total of 50 subjects had an anti-histamine activity in ascending order as follows:
aminophyllin, ephedrine sulfate, diphenhydramine hydrochloride, tripelennamine
hycrochloride and Hydryllin. The latter three drugs had approximately equal
anti-histamine activity of the order of 4 plus "fold of protection".
The authors wish to thank H. Davis Bruner, M.D., Ph.D., Professor of Phar-
macology, University of North Carolina, for his valuable technical advice.
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